$1.1 million on two deals announced in past 30 days to close before end of year!!!
Not a bad start for 2008. If Sequiam continues with the +$500-$750K from previous quarters from sales to existing resellers Sequiam should close out the year in a very respectable fashion. This should equate in my estimate of at least $2 million in revenue in 4th quarter and over $4 million in sales for FY 2008.
I really feel this company is turning the corner and have a feel of relief due to the fact no indications of toxic financing deals have been a concern over the past couple of months. All the while the company has needed cash to grow they haven't financed these deals in an inappropriate manner.
I really do expect the outstanding share count to increase if the share price increases due to the warrants exercisable above .21.
Having said that, I do believe the anticipated supply and possible dilution concerns from the .21 warrants will only be a temporary concern based on the fundamentals of the company going forward and more indicative of the present which we should understand in the coming weeks.
I also feel if some want to discuss the potentially dilutive share structure on Sequiam that we also bring forward the potential revenue stream that would support the share structure if all warrants above the current price converted. I understand this has been made apparent the fully dilutive amount of shares would be 168 million which is higher than the current outstanding of currently 93 million. Again, Revenue projections for next year if the fully dilutive comes into play should be around $36 million. Based on this I feel the market cap of this company is extremely low concerning comparable companies involved in the biometric industry.
Again, I'm throwing out a revenue estimate of $35 million for 2008. My potential revenue stream of this company could become a very conservative revenue estimate if Sequiam executes on the opportunites they have on the table.
Black and Decker, Fujitsu, and any speculation on Microsoft?
At .12 I feel this company has more upside than downside at this point.
I agree, with the recent association of Jake Smith/Intel, Bob Aoki/Microsoft, Chris Barrow/3-Com, and Robert Allen Barclays/Wells Fargo/ Frost and Sullivan is no coincidence.
Basically no exposure or hype of this company is in the stock price. This should not be the case in 2008.
Very happy with my investment with Sequiam and will be adding in the coming weeks.
Enjoy the Holidays!
AI
